MolNFT v2 · #177127 · protein
Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors
MolNFT v2 record #177127 on GenesisL1: PDB 7CC2, “Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors”. Protein, 310 residues. 3D structure, sequence proof, BLAST and structure search in GL1X.
- PDB
- 7CC2
- Type
- protein
- Length
- 310 residues
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.